200,617 Shares in Clover Health Investments, Corp. (NASDAQ:CLOV) Purchased by Graypoint LLC

Graypoint LLC purchased a new position in Clover Health Investments, Corp. (NASDAQ:CLOV) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 200,617 shares of the company’s stock, valued at approximately $632,000.

A number of other institutional investors also recently bought and sold shares of CLOV. Concurrent Investment Advisors LLC acquired a new stake in shares of Clover Health Investments in the third quarter worth $28,000. Sigma Planning Corp purchased a new position in shares of Clover Health Investments during the 3rd quarter valued at about $29,000. Parallax Volatility Advisers L.P. acquired a new position in shares of Clover Health Investments in the 3rd quarter valued at about $38,000. Realta Investment Advisors purchased a new stake in shares of Clover Health Investments in the third quarter worth about $44,000. Finally, Forum Financial Management LP grew its holdings in Clover Health Investments by 33.8% during the third quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock worth $45,000 after acquiring an additional 4,061 shares during the period. 19.77% of the stock is owned by hedge funds and other institutional investors.

Clover Health Investments Stock Performance

Shares of CLOV stock opened at $3.64 on Friday. The company has a market capitalization of $1.82 billion, a P/E ratio of -18.20 and a beta of 1.95. Clover Health Investments, Corp. has a 12-month low of $0.61 and a 12-month high of $4.71. The business’s 50 day moving average is $3.37 and its two-hundred day moving average is $2.92.

Clover Health Investments (NASDAQ:CLOV) last released its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.01. The firm had revenue of $330.99 million for the quarter, compared to analysts’ expectations of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same quarter last year, the company earned ($0.09) EPS. On average, research analysts predict that Clover Health Investments, Corp. will post -0.12 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on CLOV shares. Craig Hallum initiated coverage on Clover Health Investments in a research report on Tuesday, December 17th. They issued a “buy” rating and a $6.00 price objective on the stock. UBS Group assumed coverage on shares of Clover Health Investments in a research report on Monday, October 7th. They set a “neutral” rating and a $4.00 price target on the stock.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.